As per the terms of the agreement, Neomycin Sulfate tablets will be manufactured by Oman Pharma, and marketed and distributed by Breckenridge on an exclusive basis in the US.
The ANDA has been approved by the US Food and Drug Administration, and the companies began shipping the product at the start of 2011.
Breckenridge Pharma markets over 70 products in a variety of dosage forms including: tablets, capsules, soft gel capsules, liquids, suspensions and powders.